Assessment of Drug Susceptibility for Patient-Derived Tumor Models through Lactate Biosensing and Machine Learning-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of Drug Susceptibility for Patient-Derived Tumor Models through Lactate Biosensing and Machine Learning

Published:2023-02-14 Issue:2 Volume:8 Page:803-810
ISSN:2379-3694
Container-title:ACS Sensors
language:en
Short-container-title:ACS Sens.

Author:

Zhang Jingfeng¹,Hong Zichen¹,Lu Wei²,Fang Tianyuan¹,Ren Yongan¹,Yin Shenyi³,Xuan Qijia⁴,Li Dezhi⁴,Xi Jianzhong Jeff³,Yao Bo¹^ORCID

Affiliation:

1. Department of Chemistry, Zhejiang University, Hangzhou 310058, China

2. GeneX (Zhejiang) Precision Medicine Co., Ltd., Hangzhou 311100, China

3. College of Future Technology, Peking University, Beijing 100871, China

4. Department of Oncology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China

Funder

National Natural Science Foundation of China

Jinhua Science and Technology Bureau

Yiwu Science and Technology Bureau

Publisher

American Chemical Society (ACS)

Subject

Fluid Flow and Transfer Processes,Process Chemistry and Technology,Instrumentation,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acssensors.2c02381

Reference34 articles.

1. International Agency for Research on Cancer CSU Branch. Global Cancer Observatory (GCO)[DB/OL], 2020.

2. Tumour heterogeneity and resistance to cancer therapies

3. Combinatorial drug therapy for cancer in the post-genomic era

4. Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution

5. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human patient derived organoids: an emerging precision medicine model for gastrointestinal cancer research;Frontiers in Cell and Developmental Biology;2024-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3